First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by December 15, 2025.
First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by December 15, 2025.
Executive Director
The Saudi Food and Drug Authority
Saudi Arabia
Ali Alhomaidan, a dynamic professional dedicated to helping individuals and organizations meet and exceed their goals. He is highly skilled in a “leading from the front” management approach, consistently demonstrating exceptional communication and interpersonal abilities. His talent for building strong relationships, managing competing priorities, and guiding diverse teams in fast-paced and evolving business environments distinguishes him as an effective and influential leader.
Mr. Alhomaidan is ideally suited for leadership roles across pharmaceutics, Good Manufacturing Practice (GMP), clinical research, biotechnology, and validation. An innovative visionary, he brings extensive and comprehensive experience within the Pharmaceutical and Biotech industries. Known for being creative, open-minded, enthusiastic, organized, and hands-on, he has established a remarkable career characterized by consistent high performance and notable achievements.
He has repeatedly proven his ability to rapidly understand and communicate complex situations while fostering effective governance and driving positive change. His leadership contributions have significantly enhanced productivity, efficiency, and revenue across multiple settings.